About the Company
We do not have any company description for Artiva Biotherapeutics, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc.: Strong Buy Rating Supported by Robust ...
Artiva Biotherapeutics, Inc. (ARTV – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Gil Blum from Needham maintained a Buy rating on the ...
Artiva Biotherapeutics, Inc. (ARTV) - Yahoo Finance
SAN DIEGO, March 31, 2025 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe, and accessible cell ...
Artiva Biotherapeutics, Inc. (ARTV) Receives a Buy from TD Cowen
TD Cowen analyst Tyler Van Buren maintained a Buy rating on Artiva Biotherapeutics, Inc. (ARTV – Research Report) yesterday. The company’s shares closed yesterday at $13.07. Van Buren covers ...
Artiva Biotherapeutics Readies for the Next Phase of Growth with the ...
SAN DIEGO--(BUSINESS WIRE)--Artiva Biotherapeutics, Inc., a clinical-stage company whose mission is to deliver broadly accessible, off-the-shelf natural killer (NK) cell-based therapies to ...
Artiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its Board of ...
SAN DIEGO, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe, and accessible cell ...
Artiva Biotherapeutics Appoints Edith A. Perez, M.D., to Its Board of ...
Artiva Biotherapeutics Appoints Edith A. Perez, M.D., to Its Board of Directors and Clinical Advisory Board May 05, 2022 08:00 AM Eastern Daylight Time ...
Brokerages Set Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Price Target ...
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV – Get Free Report) has earned a consensus recommendation of “Buy” from the six ratings firms that are covering the company, Marketbeat Ratings reports.
Artiva Biotherapeutics, Inc.: Artiva Biotherapeutics Appoints Subhashis ...
Aktien»Nachrichten»ARTIVA BIOTHERAPEUTICS AKTIE» ARTIVA BIOTHERAPEUTICS INC WKN: A3CPAK|ISIN: US04317A1079|Ticker-Symbol: NASDAQ 18.06.25 | 21:39 1,690US-Dollar +0,60 % +0,010 Branche ...
Artiva Biotherapeutics Inc News (ARTV) - Investing.com
Artiva Biotherapeutics to Participate in the TD Cowen 45th Annual Health Care Conference SAN DIEGO, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage ...
Artiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its ... - Nasdaq
--Artiva Biotherapeutics, Inc., a clinical-stage biotechnology company whose mission is to develop effective, safe, and accessible cell therapies for patients with devastating autoimmune diseases ...
Artiva Biotherapeutics Inc News (ARTV) - Investing.com
Artiva Biotherapeutics, Inc. (Nasdaq: ARTV) today announced the pricing of its upsized initial public offering of 13,920,000 shares of common stock at a price to the public of ...
Similar Companies
Loading the latest forecasts...